Cochlear | COH - Operating Expenses

Stock Price
173.62
Daily Change
0.55 0.32%
Monthly
-12.25%
Yearly
-35.33%
Q1 Forecast
170.76

Cochlear reported AUD914.9M in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Ansell USD 880.1M 465.65M Dec/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Cochlear AUD 914.9M 454.8M Dec/2025
CSL USD 5.7B 2.82B Dec/2025
Fisher Paykel Healthcare NZD 802.4M 24.1M Dec/2025
Healius AUD 684.9M 261.2M Dec/2024
Integral Diagnostics AUD 219.16M 66.76M Jun/2024
Mayne Pharma AUD 103.54M 9.39M Jun/2024
Mesoblast USD 56.15M 32.57M Jun/2025
Monash IVF AUD 119.86M 61.99M Dec/2025
Nanosonics AUD 93.11M 45.89M Dec/2025
Polynovo AUD 27.51M 19.08M Jun/2024
Ramsay Health Care AUD 8.8B 83.5M Dec/2025
Regis Healthcare AUD 643.07M 113.42M Dec/2025
ResMed USD 922.51M 49.28M Dec/2025
Sigma Healthcare AUD 1.68B 174.89M Dec/2024
Somnomed AUD 47.82M 4.98M Jun/2023
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Telix Pharmaceuticals AUD 405.4M 26.29M Dec/2025